Fierce Biotech December 8, 2023
Andrea Park

This week, Tandem Diabetes Care’s t:slim X2 insulin pump and Control-IQ algorithm made headlines as they became the first to integrate with Dexcom’s G7 sensor to create an artificial pancreas system. A mere 24 hours later, they’re already having to share the spotlight.

On Thursday, the day after Dexcom announced the Tandem team-up, Beta Bionics revealed that its technology, too, has been tapped to link with the G7 continuous glucose monitor. In this case, the resulting automated insulin delivery system will comprise Dexcom’s sensor plus Beta Bionics’ insulin pump and dosing software, which together have been dubbed the iLet Bionic Pancreas and were previously compatible only with Dexcom’s G6 sensor.

The iLet system was cleared by the FDA earlier this...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices
GE HealthCare & AWS to Develop Foundation Models & Generative AI Apps
Bone Health Technologies Acquires Wellen to Deliver Personalized, Non-Drug Osteoporosis Care
Edwards spends $1.2B on 2 heart device firms, extending deal streak
Amazon Web Services, GE HealthCare to build healthcare AI tools
TRiCares raises $50m to trial tricuspid heart valve replacement system

Share This Article